Single-nucleotide polymorphism in the 5-α-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors
Titel:
Single-nucleotide polymorphism in the 5-α-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors
Auteur:
Boer, Hink Westerink, Nico-Derk L. Altena, Renske Nuver, Janine Dijck-Brouwer, D.A. Janneke van Faassen, Martijn Klont, Frank Kema, Ido P. Lefrandt, Joop D. Zwart, Nynke Boezen, H. Marike Smit, Andries J. Meijer, Coby Gietema, Jourik A.